Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFatigue is a recognised side effect of semaglutide, the active ingredient in Wegovy, and it tends to appear in the first few weeks of treatment or after a dose increase. It happens partly because your body is adjusting to lower calorie intake, and partly because of the way the medicine affects the brain's energy-regulation signals. It settles for most people within two to four weeks. These are prescription-only medicines; a clinician assesses whether they're right for you before anything is prescribed, and side effects are always part of that conversation. If you're already on Wegovy and wondering why tiredness has crept in, you're asking exactly the right question — and the answer is more straightforward than most people expect. You can read more about the broader side-effect profile of Wegovy if you want the wider picture alongside this.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people feel tired in the first weeks on semaglutide and assume something has gone wrong, that they're reacting badly, that the dose is too high, or that Wegovy simply isn't for them. In most cases, none of those things is true. The tiredness is a normal physiological response to a significant shift in how your body is handling appetite, food intake and energy balance. Stopping early because of it often means missing out on a period where the medicine is, in fact, beginning to work.
Semaglutide is a GLP-1 receptor agonist. It activates receptors that influence hunger signalling, gastric emptying and, crucially, pathways in the brain that regulate appetite and reward. Those same central pathways play a role in how energised or flat you feel day to day. When they're adjusted (even usefully) there can be a period of adaptation that reads as low energy. If you want a fuller explanation of whether semaglutide can cause fatigue and why it happens, we cover the mechanisms in detail on a dedicated page. The NHS patient guide on semaglutide lists tiredness among the recognised common side effects, in the same category as the more familiar nausea and headache.
The other factor people underestimate is the calorie shift. A meaningful drop in appetite usually means eating less, which means less glucose reaching the muscles and brain. That gap can feel like fatigue even before any weight change is visible. Protein intake in particular tends to fall when overall eating drops, and that can make the tiredness more pronounced. Keeping protein reasonably consistent (something to discuss with your prescriber) often makes a noticeable difference.
Timing is a useful clue. Semaglutide-related fatigue almost always clusters around two moments: the start of treatment, and the days following each dose increase. The step-up schedule (from 0.25mg through progressively higher maintenance doses) is designed to let your body adjust gradually, but each rung still involves a fresh adaptation period. For many people, a dose change on, say, a Tuesday means feeling more tired than usual by Thursday or Friday, then recovering over the following week.
If you take your weekly injection and then check it off as part of your morning routine (next to the kettle, or wherever your pen sits between uses) keeping a brief note of how you feel in the days that follow can help you spot the pattern. Many people find tiredness correlates almost exactly with injection timing, which is reassuring: it makes the cause clear and gives you a realistic window for when it should ease.
Nausea and poor sleep also compound the picture. Gastrointestinal discomfort is common early in treatment and can disrupt sleep quality, which shows up as daytime fatigue. These effects are related but distinct, how semaglutide-related fatigue and other side effects interact is worth understanding if multiple symptoms are overlapping for you. The Mounjaro and Wegovy SmPCs on the eMC contain the full side-effect frequency data if you want the clinical detail.
Most semaglutide-related fatigue is self-limiting and manageable. But there are situations where tiredness is a signal that needs prompt attention, not patience.
Contact your prescriber or GP without delay if tiredness is severe and sudden rather than gradual, if it's accompanied by severe abdominal pain that radiates to the back (which can indicate pancreatitis, the MHRA highlighted this in a Drug Safety Update in January 2026), or if you notice yellowing of the skin or eyes, significant breathlessness, chest pain, or dark urine alongside fatigue. Rapid unexplained weight loss beyond what you'd expect, or feeling faint or dizzy when standing, can signal dehydration that needs addressing actively.
Low mood or persistent low motivation that doesn't lift after the first few weeks is also worth raising with your prescriber, not all tiredness is physical. If you're curious whether the medicine might, over time, have a positive effect on mood and energy, the evidence on Wegovy and mood is discussed separately and may be useful context.
You can report any suspected side effect, including unusual fatigue, directly to the MHRA via the Yellow Card scheme. This isn't just a formality: Yellow Card reports actively shape prescriber guidance and safety communications. Our prescribers at nume discuss side effects (including fatigue) as part of every consultation, so if you're considering treatment, checking your eligibility is the natural first step.
There's no single fix, but several practical steps reliably reduce how pronounced semaglutide-related fatigue feels. Hydration is probably the most underrated: nausea blunts thirst, and many people on GLP-1 treatment are drinking less than usual without noticing. Aiming for steady fluid intake across the day (not just a large amount in one go) tends to help more than any supplement.
Timing injections deliberately can also make a difference. Some people find that injecting in the evening means any peak side effects, including tiredness, occur during sleep. Others prefer morning. Neither is clinically superior; it's a lifestyle question worth experimenting with and discussing with your prescriber.
Gentle activity (a short walk, rather than skipping exercise entirely) often improves energy levels more than rest alone, particularly once the first two weeks have passed. Vigorous training in the adaptation window tends to be counterproductive. If you're at the stage of considering treatment rather than already on it, the full Wegovy overview covers the wider context of how the treatment works and what to expect. And if you'd like to understand the access route in more detail, where to get Wegovy in the UK explains the prescription process clearly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.